Marpai Inc (MRAI)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Marpai Inc Stock (MRAI) Company Profile

Healthcare (1087)

Healthcare Plans (14)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

MRAI's Discussions on Twitter

Compare MRAI vs UNH, CVS, ELV, CI, HUM

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MRAI Marpai Inc	2.4968	0	18.10M	-16.56M	-7.45M	-0.9561
UNH Unitedhealth Group Inc	395.22	345.44B	450.13B	14.91B	23.62B	15.55
CVS Cvs Health Corp	96.80	119.78B	407.94B	2.90B	7.39B	2.2771
ELV Elevance Health Inc	402.45	85.94B	201.11B	4.95B	6.29B	22.50
CI Cigna Group	282.12	72.51B	278.13B	6.74B	7.66B	23.60
HUM Humana Inc	390.90	45.72B	137.20B	1.15B	1.27B	9.3439

Marpai Inc Aktie (MRAI) Neueste Nachrichten

Finanzdaten der Marpai Inc-Aktie (MRAI)

Marpai Inc (MRAI)

Marpai Inc Stock (MRAI) Company Profile

Compare MRAI vs UNH, CVS, ELV, CI, HUM

Marpai Inc Aktie (MRAI) Neueste Nachrichten

Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients - 01net

Marpai expands Claritev agreement for payment integrity - Investing.com

Marpai expands beyond network access—but what comes next? - Stock Titan

Marpai Expands Relationship With Claritev To Help Reduce Healthcare Costs For Employer Clients - TradingView

Marpai, Inc. Expands Relationship with Claritev Corporation to Help Reduce Healthcare Costs for Employer Clients - marketscreener.com

Marpai Q2 revenue down 10.5% to USD 4.2M - Medical Buyer

Marpai Q2 loss per share narrows to $(0.18) as revenue falls 10.5% - scanx.trade

Marpai Q2 revenue falls due to turnover and continued customer pruning - TradingView

Marpai Reports Second Quarter 2026 Financial Results - PR Newswire

Marpai, Inc. (MRAI) flags going-concern risk amid heavy debt and losses - Stock Titan

Marpai (MRAI) investor group discloses 10.1% stake and board observer rights - Stock Titan

Calvin Steven Mitchell Discloses Investment at Marpai, Inc. with 9.3% Stake - TradingView

Marpai, Inc. (MRAI) gains 9.3% shareholder as Mitchell and Benchmark file 13D - Stock Titan

Marpai, Inc. (MRAI) insider details warrants and 3M-share preferred conversion - Stock Titan

Marpai, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Enterprise value to EBITDA forward of Marpai, Inc. – OTC:MRAI - TradingView

Marpai Raises $12.1 Million in Series A Preferred Private Placement Led by Mitchell Companies - TradingView

Marpai lands $12.1M private placement led by Mitchell Companies - Dealroom

Marpai raises $12 million in private placement By Investing.com - Investing.com Nigeria

Marpai Announces $12 Million Private Placement led by Mitchell Companies - PR Newswire

Price to sales forward of Marpai, Inc. – OTC:MRAI - TradingView

Marpai Highlights Major Debt Restructuring to Boost Flexibility - The Globe and Mail

Marpai Restructures AXA Maestro Purchase Payments; Defers 35% Proceeds Until $5M Raised - TradingView

Marpai Restructures Debt, Cuts Near-Term Debt Service by $26.4 Million - citybiz

Marpai Extends Debt Maturities to April 2028 and Dec. 2029 - Stock Titan

Dallas Scrip Net Worth (2026) - GuruFocus

Marpai CFO Steve Johnson buys $682 in stock, granted award By Investing.com - Investing.com India

[Form 4] Marpai, Inc. Insider Trading Activity - Stock Titan

Marpai CFO Steve Johnson buys $682 in stock, granted award - Investing.com

Marpai (MRAI) director receives 175,000-share grant and forfeits 50,000 RSUs - Stock Titan

Marpai (MRAI) director reports 125,000-share RSU grant and 50,000 RSU forfeiture - Stock Titan

Marpai (MRAI) director reports 100K RSU grant and 484K shares - Stock Titan

Marpai (MRAI) director gets 100,000-share RSU grant, forfeits 50,000 - Stock Titan

Marpai (MRAI) director DiClaudio receives 125,000-share fully vested stock grant - Stock Titan

Marpai secures 192,000 new member lives, projects profitability - Investing.com

Marpai Inc. Announces Unprecedented Growth with 192,000 New Estimated Member Lives Across TPA and MarpaiRx PBM Platforms; Expects to Achieve Positive Cash Flow and EBITDA Beginning August 2026 - PR Newswire

Marpai (MRAI) director Eitan Yaron adds 10,000 shares in open-market buy - Stock Titan

MARPAI reports net loss of USD 3.2M in Q1 2026 - Medical Buyer

Marpai reports Q1 2026 results with cloud migration nearing completion and targets profitability in H2 2026 - Pluang

Marpai reports Q1 loss, targets second-half profitability - Investing.com

Marpai reports Q1 loss, targets second-half profitability By Investing.com - Investing.com Nigeria

Marpai (MRAI) Q1 2026 shows losses, heavy debt and going concern risk - Stock Titan

BRIEF-Marpai Q1 Revenue USD 4.4 Million - TradingView

MARPAI REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS - PR Newswire

Marpai secures major new contracts, boosting path to profitability with integrated healthcare services. - Pluang

Marpai, Inc. Announces Significant New Business Wins across TPA and MarpaiRx; Solidifies Forecast for Profitability - The Norfolk Daily News

Marpai Extends Maturity of Insider Promissory Notes - TipRanks

Marpai (MRAI) pushes $660,000 CEO promissory notes out to Sept. 1, 2026 - Stock Titan

Marpai, Inc. (MRAI) - Minichart

Marpai (MRAI) director receives 100,000 RSUs tied to strategic deal - Stock Titan

Marpai, Inc. Secures Major Strategic Marketing Collaboration to Continue Acceleration of MarpaiRx Growth Nationwide - PR Newswire

Finanzdaten der Marpai Inc-Aktie (MRAI)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie MRAI